Microglia polarization from M1 to M2 in neurodegenerative diseases
S Guo, H Wang, Y Yin - Frontiers in aging neuroscience, 2022 - frontiersin.org
Microglia-mediated neuroinflammation is a common feature of neurodegenerative diseases
such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis …
such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis …
Parkinson disease and the immune system—associations, mechanisms and therapeutics
Multiple lines of evidence indicate that immune system dysfunction has a role in Parkinson
disease (PD); this evidence includes clinical and genetic associations between autoimmune …
disease (PD); this evidence includes clinical and genetic associations between autoimmune …
Role of microglia in neurological disorders and their potentials as a therapeutic target
L Du, Y Zhang, Y Chen, J Zhu, Y Yang… - Molecular neurobiology, 2017 - Springer
Microglia are resident macrophage-like immune cells in the central nervous system (CNS)
and play a vital role in both physiological and pathological conditions, including restoring …
and play a vital role in both physiological and pathological conditions, including restoring …
Central role of microglia in sepsis-associated encephalopathy: from mechanism to therapy
X Yan, K Yang, Q Xiao, R Hou, X Pan… - Frontiers in …, 2022 - frontiersin.org
Sepsis-associated encephalopathy (SAE) is a cognitive impairment associated with sepsis
that occurs in the absence of direct infection in the central nervous system or structural brain …
that occurs in the absence of direct infection in the central nervous system or structural brain …
Microglia in Alzheimer's disease: Pathogenesis, mechanisms, and therapeutic potentials
J Miao, H Ma, Y Yang, Y Liao, C Lin, J Zheng… - Frontiers in aging …, 2023 - frontiersin.org
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by protein
aggregation in the brain. Recent studies have revealed the critical role of microglia in AD …
aggregation in the brain. Recent studies have revealed the critical role of microglia in AD …
Dynamic changes in pro-and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive …
Neuroinflammatory changes play a pivotal role in the progression of Parkinson's disease
(PD) pathogenesis. Recent findings have suggested that activated microglia may polarize …
(PD) pathogenesis. Recent findings have suggested that activated microglia may polarize …
The ongoing pursuit of neuroprotective therapies in Parkinson disease
D Athauda, T Foltynie - Nature Reviews Neurology, 2015 - nature.com
Many agents developed for neuroprotective treatment of Parkinson disease (PD) have
shown great promise in the laboratory, but none have translated to positive results in …
shown great promise in the laboratory, but none have translated to positive results in …
[HTML][HTML] Pathogenesis-targeted, disease-modifying therapies in Parkinson disease
Parkinson disease is an inexorably progressive neurodegenerative disorder. Multiple
attempts have been made to establish therapies for Parkinson disease which provide …
attempts have been made to establish therapies for Parkinson disease which provide …
Microglial polarization in TBI: Signaling pathways and influencing pharmaceuticals
YF Li, X Ren, L Zhang, YH Wang… - Frontiers in aging …, 2022 - frontiersin.org
Traumatic brain injury (TBI) is a serious disease that threatens life and health of people. It
poses a great economic burden on the healthcare system. Thus, seeking effective therapy to …
poses a great economic burden on the healthcare system. Thus, seeking effective therapy to …
The antidepressant-like effects of pioglitazone in a chronic mild stress mouse model are associated with PPARγ-mediated alteration of microglial activation …
Background Discoveries that microglia-mediated neuroinflammation is involved in the
pathological process of depression provided a new strategy for novel antidepressant …
pathological process of depression provided a new strategy for novel antidepressant …